Jump to content

Meta-Chlorophenylpiperazine: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

10 March 2024

1 January 2024

14 December 2023

7 November 2023

27 September 2023

20 September 2023

28 August 2023

24 July 2023

4 April 2023

24 March 2023

2 December 2022

2 October 2022

23 August 2022

9 May 2022

29 April 2022

24 April 2022

23 January 2022

20 November 2021

1 November 2021

20 October 2021

22 August 2021

10 July 2021

6 June 2021

14 January 2021

5 January 2021

2 December 2020

25 October 2020

13 October 2020

19 June 2020

27 May 2020

  • curprev 00:5900:59, 27 May 2020Minebynight talk contribs 33,609 bytes −26 →‎Pharmacodynamics: Article does not prove mCPP is a 5-ht2b antagonist: "One caveat to the present studies is that the results are based solely on radioligand binding data which provide no insight into the agonist, partial agonist, or antagonist nature of these compounds at 5-HT2B receptors." Closest reference is: "mCPP is a 5-HT2C agonist (Nelson, unpublished findings) but a 5-HT2A antagonist (Cohen and Fuller 1983)" undo Tag: Visual edit

12 April 2020

31 January 2020

8 December 2019

18 November 2019

17 November 2019

7 October 2019

21 September 2019

15 August 2019

2 August 2019

25 July 2019

3 July 2019

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)